These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7780867)
1. From thrombolytic megatrials to clinical policy-making: facing the facts. Naylor CD; Armstrong PW Can J Cardiol; 1995 Jun; 11(6):472-6. PubMed ID: 7780867 [No Abstract] [Full Text] [Related]
2. [Thrombolytic treatment of acute myocardial infarct. 1]. Soares-Costa JT; Soares-Costa TJ; Gabriel HM Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051 [TBL] [Abstract][Full Text] [Related]
3. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study]. Franzosi MG Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828 [No Abstract] [Full Text] [Related]
4. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). Indian Heart J; 2001; 53(3):375. PubMed ID: 11516047 [No Abstract] [Full Text] [Related]
5. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941 [No Abstract] [Full Text] [Related]
6. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction. Johnson TJ S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948 [No Abstract] [Full Text] [Related]
7. Acute myocardial infarction. A guide for North Carolina doctors. Williams ML; O'Meara JJ; Tate DA; Simpson RJ N C Med J; 1995 Aug; 56(8):390-7. PubMed ID: 7566193 [No Abstract] [Full Text] [Related]
8. Interpreting results from thrombolytic megatrials: distinguishing fact from fiction. Brophy JM Can J Cardiol; 1996 Jan; 12(1):89-92. PubMed ID: 8595575 [No Abstract] [Full Text] [Related]
9. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
10. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction. McGahan L Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221 [No Abstract] [Full Text] [Related]
11. Clot-busting drugs linked to increased mortality in the very elderly. Levenson D Rep Med Guidel Outcomes Res; 2002 Apr; 13(7):1-2, 5. PubMed ID: 12452167 [No Abstract] [Full Text] [Related]
12. The ideal fibrinolytic: can drug design improve clinical results? Van de Werf FJ Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843 [No Abstract] [Full Text] [Related]
15. Fibrinolysis and activators of plasminogen. Sobel BE Heart Lung; 1987 Nov; 16(6 Pt 2):775-9. PubMed ID: 3119522 [No Abstract] [Full Text] [Related]
16. [Experience with the thrombolytic therapy of myocardial infarct]. Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; VrublevskiÄ OIu; Makarenko AS; SokolianskiÄ NV; Chernov SA; Kucherov VV; Davrent'eva TA Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835 [No Abstract] [Full Text] [Related]
17. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice. Hoffman JR Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529 [No Abstract] [Full Text] [Related]